HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neera Tewari-Singh Selected Research

Mechlorethamine (Nitrogen Mustard)

1/2022Effect of dexamethasone treatment at variable therapeutic windows in reversing nitrogen mustard-induced corneal injuries in rabbit ocular in vivo model.
10/2021Mast Cells Promote Nitrogen Mustard-Mediated Toxicity in the Lung Associated With Proinflammatory Cytokine and Bioactive Lipid Mediator Production.
10/2019Acute corneal injury in rabbits following nitrogen mustard ocular exposure.
9/2018Efficacy of anti-inflammatory, antibiotic and pleiotropic agents in reversing nitrogen mustard-induced injury in ex vivo cultured rabbit cornea.
2/2016Nitrogen Mustard-Induced Corneal Injury Involves DNA Damage and Pathways Related to Inflammation, Epithelial-Stromal Separation, and Neovascularization.
5/2015Flavanone silibinin treatment attenuates nitrogen mustard-induced toxic effects in mouse skin.
6/2014Myeloperoxidase deficiency attenuates nitrogen mustard-induced skin injuries.
9/2013Absence of a p53 allele delays nitrogen mustard-induced early apoptosis and inflammation of murine skin.
1/2013Clinically-relevant cutaneous lesions by nitrogen mustard: useful biomarkers of vesicants skin injury in SKH-1 hairless and C57BL/6 mice.
10/2012Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Neera Tewari-Singh Research Topics

Disease

16Wounds and Injuries (Trauma)
10/2021 - 04/2011
10Inflammation (Inflammations)
10/2021 - 12/2009
8Corneal Injuries
01/2022 - 01/2016
3Edema (Dropsy)
12/2016 - 03/2009
2Toxic Optic Neuropathy
01/2022 - 04/2020
2Eye Injuries (Eye Injury)
09/2018 - 10/2012
2Blister (Bulla)
12/2017 - 05/2015
2Necrosis
12/2016 - 06/2010
1Corneal Opacity
01/2022
1Lung Injury
10/2021
1Skin Manifestations
01/2017
1Blindness (Hysterical Blindness)
12/2016
1Disease Progression
12/2016
1Photophobia (Light Sensitivity)
01/2016
1Corneal Edema
01/2016
1Parakeratosis
05/2015
1Myeloperoxidase Deficiency
06/2014
1Ataxia (Dyssynergia)
06/2010
1Ataxia Telangiectasia (Louis Bar Syndrome)
06/2010
1Type 2 Diabetes Mellitus (MODY)
01/2007

Drug/Important Bio-Agent (IBA)

14Mustard Gas (Sulfur Mustard)IBA
01/2022 - 06/2010
10Irritants (Vesicants)IBA
01/2022 - 01/2012
10Mechlorethamine (Nitrogen Mustard)FDA Link
01/2022 - 10/2012
82-chloroethyl ethyl sulfideIBA
07/2014 - 03/2009
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 02/2016
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2019 - 09/2011
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2019 - 09/2011
4Silybin (Lagosa)IBA
09/2018 - 01/2012
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 10/2012
3Biological ProductsIBA
01/2022 - 06/2010
3Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2012
2Oxygen (Dioxygen)IBA
10/2021 - 01/2020
2HCEIBA
04/2020 - 02/2016
2Interleukin-8 (Interleukin 8)IBA
10/2019 - 12/2017
2Doxycycline (Periostat)FDA LinkGeneric
09/2018 - 10/2012
2Chemical Warfare AgentsIBA
07/2014 - 01/2012
2Phosphotransferases (Kinase)IBA
09/2011 - 06/2010
1Prostaglandin D2IBA
10/2021
1Interleukin-6 (Interleukin 6)IBA
10/2021
1PesticidesIBA
10/2021
1EmulsionsIBA
01/2020
1Peroxidase (Myeloperoxidase)IBA
01/2017
1lewisiteIBA
12/2016
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
02/2016
1Transcription Factors (Transcription Factor)IBA
02/2016
1Mitogen-Activated Protein KinasesIBA
02/2016
1Protein Kinases (Protein Kinase)IBA
02/2016
1Proteins (Proteins, Gene)FDA Link
02/2016
1AntidotesIBA
05/2015
1AEOL 10150IBA
07/2014
1Oxidants (Oxidizing Agents)IBA
06/2014
1CollagenIBA
03/2014
1Alkylating AgentsIBA
09/2013
1flavanoneIBA
10/2012
1SteroidsIBA
10/2012
1Anti-Bacterial Agents (Antibiotics)IBA
10/2012
1Prescription DrugsIBA
10/2012
1Matrix Metalloproteinase InhibitorsIBA
10/2012
1CaspasesIBA
06/2010
1A-Form DNA (A-DNA)IBA
06/2010
1Cell Cycle ProteinsIBA
06/2010
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2007
1Advanced Glycation End ProductsIBA
01/2007
1NF-kappa B (NF-kB)IBA
01/2007
1CytokinesIBA
01/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2007

Therapy/Procedure

11Therapeutics
10/2021 - 04/2011